Delay, deny, and defend: Public outrage at health insurance companies and stock market debacle. [PDF]
Li C, Dutta M, Duo J, Dutta S.
europepmc +1 more source
Impact of Market Authorization Holder (MAH) system on pharmaceutical innovation in China. [PDF]
Zhai S +8 more
europepmc +1 more source
Risk seeking or averse, how do analyst coverage and firm visits motivate managers? [PDF]
Liu H, Guo X, Sheng D.
europepmc +1 more source
The Relative Value Relevance of Shareholder versus Stakeholder Corporate Governance Disclosure Policy Reforms in South Africa [PDF]
Collins G. Ntim +2 more
openalex +1 more source
Association of potential biomarkers with clinical outcomes in metastatic triple-negative breast cancer treated with pembrolizumab or chemotherapy. [PDF]
Cortes J +19 more
europepmc +1 more source
Innovation and valuation of Chinese born-global firms. [PDF]
Cai R, Zhang C, Xie Y, Kim M.
europepmc +1 more source
Linking corporate reputation and shareholder value using the publication of reputation rankings [PDF]
Sven Tischer, Lutz Hildebrandt
openalex +1 more source
Three-Plane Alignment of the Second Metatarsal Improves Reliability of Weightbearing CT Measurements in Lisfranc Injury Assessment. [PDF]
GrĂ¼n W +7 more
europepmc +1 more source

